NO2022022I1
(no )
2022-06-09
Fedratinib, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate thereof, in particular fedratinib dihydrochloride monohydrate
IL183658A0
(en )
2007-09-20
Solid dosage form comprising proton pump inhibitor and suspension made thereof
IL173490A0
(en )
2006-06-11
4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
PL372814A1
(en )
2005-08-08
Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
IL180078A
(en )
2014-01-30
Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
IL183101A
(en )
2015-04-30
Use of tetrahydrocannabivarin in drug production
IL192053A
(en )
2014-01-30
2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
IL182261A0
(en )
2007-07-24
Therapeutic agents with decreased toxicity
IL190284A
(en )
2014-01-30
Use of milenzipran, or a suitable pharmaceutical salt, in the preparation of a drug for the treatment of fibromyalgia
GB0324761D0
(en )
2003-11-26
Use of compounds in therapy
GB0400700D0
(en )
2004-02-18
Compounds useful in therapy
ZA200510319B
(en )
2007-03-28
6-arylamino-5-cyano-4-pyrimidinones as PDE9a inhibitors
AU2003293998A1
(en )
2004-11-04
Use of alkyl resorcinols in the treatment of acne
IL177709A0
(en )
2006-12-31
Caspase inhibitors and uses thereof
ZA200703488B
(en )
2008-09-25
Dicarboxamide derivatives and their use as factor Xa inhibitors
EP1757282A4
(en )
2010-02-10
USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
ZA200705080B
(en )
2008-08-27
Aminocarboxylic acid derivative and medicinal use thereof
ZA200703478B
(en )
2008-07-30
Therapeutic agents with decreased toxicity
AP2007004052A0
(en )
2007-06-30
Use of surfactants in the production of metal
EP2111860A4
(en )
2009-10-28
INFLAMMATION INHIBITING AGENT COMPRISING AN ACYLAMINATED ACID ZINC SALT
SI1651217T1
(sl )
2008-08-31
Alkalne soli inhibitorjev protonske ÄŤrpalke
SI1664044T1
(sl )
2007-12-31
S-tenatoprazol natrijev monohidratna sol in njenauporaba v obliki protonskega äśrpalnega inhibitorja
EP1786415A4
(en )
2010-01-20
METABOLISM MODULATION AGENTS AND USES THEREOF
EP1622603A4
(en )
2010-03-24
GABAPENTINIC PHENOLIC ACID SALTS IN SOLID DOSAGE FORMS AND METHODS OF USE
AU2003222258A8
(en )
2003-09-22
Inhibitors for use in hemostasis